4[1]Laggarou J, Pomeranz BH, Cerey PN. Incidnce of adverse drug reactions in hospitalied patients, a meta- analysis of prospective studies. JAMA, 1998, 279:1205
5[2]The FDA and drug safety. Del Med, 1999, 70:405
6[3]Friedman MA, Woodcock J, Lumpkin MM, et al. The safety of newly approved medicines: do recent market removals mean there is problem?JAMA, 1999, 281:1728
7[4]Wood AJ. The safety of new medicines; The importance of asking right question. JAMA, 1999, 281:1753
8[5]Ajayi FO, Sun H, Perry J. Adverse drug reactions: a review of relevant factors. J Clin Pharmacol, 2000, 40:1093
9[6]Kamatak T, Yokoi T, Yamayoshi Y, et al. Strategic Proposals to avoid toxic drug intereactions during new drug development:molecular toxicology proposals. J Toxicol Sci, 1996, 21:305
10[7]Anastasio GD, Cornell K, Menscer D. Drug interaction: keeping it straight. Am Fam Physician, 1997, 56:883,891
